Reports
Global Uveitis Drugs Market Size, Share, Trends, Forecast: By Product: Small Molecules, Biologics; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Competitive Landscape; Industry Events and Developments; 2024-2032
Global Uveitis Drugs Market Outlook
The global uveitis drugs market is estimated to grow at a CAGR of almost 6.8% in the forecast period of 2024-2032. The global uveitis drugs market is being driven by the increased prevalence of eye disorders, the growing preference for combination therapies, and the development of novel diagnostic tools and solutions to treat patients with uveitis.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Segmentation
Uveitis is associated with several inflammatory diseases, which results in the swelling of the eye and destroy eye tissues. The global uveitis drugs market can be divided based on segments like products and regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
- Product:
- Small Molecules
- Biologics
The EMR report looks into the regional uveitis drugs markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
With the advancement in technology and development in the field of uveitis drugs, the uveitis drugs market is witnessing an increased growth. The growing preference for AI-based medical devices to analyse the level of diabetic retinopathy and improved diagnostic tools and methods to treat patients with uveitis are expected to aid the uveitis drugs market growth in the future. Further, the growing investments in R&D by major players and the deployment of advanced technology are expected to provide a further boost to the uveitis drugs market growth.
The small molecules segment, among other product types, is expected to lead the global uveitis drugs industry over the forecast period owing to the growing utilisation of corticosteroids to treat uveitis. Region-wise, the Asia Pacific is expected to witness the highest growth rate over the forecast period owing to the growing prevalence of uveitis and the increased efforts by various governments and private organisations, creating awareness regarding the disease and its treatment, which will provide the industry with significant growth opportunities.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global uveitis drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- AbbVie Inc. (NYSE: ABBV)
- Allergan Plc
- Johnson & Johnson Services Inc.
- Novartis AG
- Pfizer Inc.
- Others
The EMR report gives an in-depth insight into the uveitis drugs market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Region |
| Breakup by Product | Small Molecules, Biologics |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | AbbVie Inc. (NYSE: ABBV), Allergan Plc (NYSE: AGN), Johnson & Johnson Services Inc. (NYSE: JNJ), Novartis AG (SWX: NOVN), Pfizer Inc. (NYSE: PFE), Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Uveitis Drugs Market Analysis
8.1 Key Industry Highlights
8.2 Global Uveitis Drugs Historical Market (2018-2023)
8.3 Global Uveitis Drugs Market Forecast (2024-2032)
8.4 Global Uveitis Drugs Market by Product
8.4.1 Small Molecules
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Biologics
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.5 Global Uveitis Drugs Market by Region
8.5.1 Market Share
8.5.1.1 North America
8.5.1.2 Europe
8.5.1.3 Asia Pacific
8.5.1.4 Latin America
8.5.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 AbbVie Inc.
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 EyePoint Pharmaceuticals, Inc.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Santen Pharmaceutical Co., Ltd.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Bausch & Lomb Incorporated
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Clearside Biomedical, Inc.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Uveitis Drugs Market: Key Industry Highlights, 2017 and 2021
2. Global Uveitis Drugs Historical Market: Breakup by Product (USD Million), 2018-2023
3. Global Uveitis Drugs Market Forecast: Breakup by Product (USD Million), 2024-2032
4. Global Uveitis Drugs Historical Market: Breakup by Region (USD Million), 2018-2023
5. Global Uveitis Drugs Market Forecast: Breakup by Region (USD Million), 2024-2032
6. North America Uveitis Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
7. North America Uveitis Drugs Market Forecast: Breakup by Country (USD Million), 2024-2032
8. Europe Uveitis Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
9. Europe Uveitis Drugs Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Asia Pacific Uveitis Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
11. Asia Pacific Uveitis Drugs Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Latin America Uveitis Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
13. Latin America Uveitis Drugs Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Middle East and Africa Uveitis Drugs Historical Market: Breakup by Country (USD Million), 2018-2023
15. Middle East and Africa Uveitis Drugs Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Global Uveitis Drugs Market Structure
Key Questions Answered in the Report
The global uveitis drugs market is projected to grow at a CAGR of 6.8% between 2021 and 2026.
The major drivers of the industry, such as the increasing prevalence of eye disorders, the growing preference for combination therapies, and the development of novel diagnostic tools and solutions to treat patients with uveitis, are expected to aid the market growth.
The key market trend guiding the industry growth includes the rising awareness regarding the disease and its treatment.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major products in the industry are small molecules and biologics.
The major players in the industry are AbbVie Inc., Allergan Plc, Johnson & Johnson Services Inc., Novartis AG, and Pfizer Inc., among others.
Analyst Review
The global uveitis drugs market is being driven by the rising prevalence of eye disorders. Aided by the technological advancements, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 6.8%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its products, the industry can be segmented into small molecules and biologics. The major regional markets for the product are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include AbbVie Inc., Allergan Plc, Johnson & Johnson Services Inc., Novartis AG, Pfizer Inc., and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER